Although Helicobacter pylori affects a large percentage of the population, only a small percentage of carriers develop peptic ulcers and gastric cancer. Recent investigations have begun to identify the factors that lead to these complications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis
SpringerPlus Open Access 13 October 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Blaser, M.J. The changing relationships of Helicobacter pylori and humans: implications for health and disease. J. Infect. Dis. 179, 1523–1530 (1999).
El-Omar E. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402 (2000).
Wang, G., Humayun, M.Z. & Taylor, D.E. Mutation as an origin of genetic variability in Helicobacter pylori. Trends Micribiol 7, 488–493 (1999).
Gerhard, M. et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA 96, 12778–12783 (1999).
Blaser, M.J., Chyou, P.H. & Nomura, A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 55, 562–565 (1995).
Nomura, A., Grove, J.S., Stemmerman, G.N. & Severson, R.K. A prospective study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption. Cancer Res 50:627–631 (1990).
Noach, L.A. et al. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol 29, 425–429 (1994).
Beales, I.L. & Calam, J. Interleukin 1β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut, 42, 227–234 (1998).
Blaser, M.J. Ecology of Helicobacter pylori in the human stomach. J. Clin. Invest. 100, 759–762 (1997).
Blaser, M.J. & Kirschner, D. Dynamics of Helicobacter pylori colonization in relation to the host response. Proc. Natl. Acad. Sci. USA 96, 8359–8364 (1999).
Tummuru, M.K.R., Sharma, S.A. & Blaser, M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18, 867–876 (1995).
Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497–1500 (2000).
Crabtree, J.E., Kersulyte, D., Li, S.D., Lindley, I.J.D. & Berg, D.E. Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue. J. Clin. Path 52, 653–657 (1999).
Kuipers, E.J. et al. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart in the same host. J. Infect. Dis 181, 273–82 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blaser, M. Linking Helicobacter pylori to gastric cancer. Nat Med 6, 376–377 (2000). https://doi.org/10.1038/74627
Issue Date:
DOI: https://doi.org/10.1038/74627
This article is cited by
-
MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis
SpringerPlus (2014)
-
Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007
European Journal of Epidemiology (2009)
-
Role of host interleukin 1β gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia
Journal of Gastroenterology (2008)
-
Host cytokine responses toHelicobacter pylori: an important determinant of clinical outcome
Irish Journal of Medical Science (2001)
-
The 'African enigma' – another explanation
Nature Medicine (2000)